Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline
Year: 2024
Type: article
Abstract: We describe herein the European Reference Network on Rare Endocrine Conditions clinical practice guideline on diagnosis and management of familial forms of hyperaldosteronism. The guideline panel consisted of 10 experts in primary aldosteronism, endocrine hypertension, paediatric endocrinology, and cardiology as well as a methodologist. A systematic literature search was conducted, and because of the rarity of the condition, most recommendations were based on expert opinion and small patient series. The guideline includes a brief description of the genetics and molecular pathophysiology associated with each condition, the patients to be screened, and how to screen. Diagnostic and treatment approaches for patients with genetically determined diagnosis are presented. The recommendations apply to patients with genetically proven familial hyperaldosteronism and not to families with more than one case of primary aldosteronism without demonstration of a responsible pathogenic variant.
Institutions: University of Turin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Pontificia Universidad Católica de Chile, National and Kapodistrian University of Athens, Biomedical Research Foundation of the Academy of Athens, Institute of Cardiology, LMU Klinikum, Ludwig-Maximilians-Universität München, University of Mississippi Medical Center, G.V. (Sonny) Montgomery VA Medical Center, The University of Queensland, Princess Alexandra Hospital, Leiden University Medical Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,316
Funder: European Commission
Award: G6454848269
OpenAlex ID: W4393942403
